Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2023-09-14 00:00:00 ET · period of report 2023-09-12 · accession 0001610717-23-000279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-09-14 | 2023-09-12 | IDYA | Throne Jason | CLO | M - OptEx | $12.86 | +1,000 | 1,000 | New | +$12.9K |
| DMT | 2023-09-14 | 2023-09-12 | IDYA | Throne Jason | CLO | S - Sale+OE | $30.00 | -1,000 | 500 | -67% | -$30.0K |
| DT | 2023-09-14 | 2023-09-12 | IDYA | Throne Jason | CLO | M - OptEx | $0.00 | -1,000 | 53.9K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-12 | M | A | 1,000 | $12.86 | 1,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-12 | S | D | 500 | $30.01 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2023-09-12 | S | D | 500 | $30.00 | 500 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-09-12 | M | D | 1,000 | $0.00 | 53,913 | D | $12.86 · — to 2032-02-29 | 1,000 Common Stock | (F2) 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |